Clinical Pharmacology Details


AMINOPHYLLINE


View Drug Forms

Indications & Dose:

Severe acute asthma in patients not previously treated with theophylline



Child: 5 mg/kg (max. per dose 500 mg), to be followed by intravenous infusion


Adult: 250–500 mg (max. per dose 5 mg/kg), to be followed by intravenous infusion


Severe acute asthma



Child 1 month–11 years: 1 mg/kg/hour, adjusted according to plasma-theophylline concentration


Child 12–17 years: 500–700 micrograms/kg/hour, adjusted according to plasma-theophylline concentration 


Adult: 500–700 micrograms/kg/hour, adjusted according to plasma-theophylline concentration


Elderly: 300 micrograms/kg/hour, adjusted according to plasma-theophylline concentration


Severe acute exacerbation of chronic obstructive pulmonary disease in patients not previously treated with theophylline



Adult: 250–500 mg (max. per dose 5 mg/kg), to be followed by intravenous infusion


Severe acute exacerbation of chronic obstructive pulmonary disease



Adult: 500–700 micrograms/kg/hour, adjusted according to plasma-theophylline concentration


Elderly: 300 micrograms/kg/hour, adjusted according to plasma-theophylline concentration


Chronic asthma



Child (body-weight 40 kg and above): Initially 225 mg twice daily for 1 week, then increased if necessary to 450 mg twice daily, adjusted according to plasmatheophylline concentration


Reversible airway obstruction



Adult (body-weight 40 kg and above): Initially 225 mg twice daily for 1 week, then increased if necessary to 450 mg twice daily, adjusted according to plasmatheophylline concentration

Contraindications:

Side Effects:

Cautions:

Precautions:

Elderly, CHF, corpulmonale, hepatic disease, preexisting dysrhythmias, hypertension, infants <1 yr, hypoxemia, sustained high fever, history of peptic ulcer, alcoholism


PREGNANCY AND LACTATION: Pharmacokinetics of theophylline may be altered during pregnancy, monitor serum concentrations carefully; excreted into breast milk; may cause irritability in the nursing infant, otherwise compatible with breast feeding

Interaction:

Drugs


Adenosine: Decreased hemodynamic effects of adenosine


Alluprinol, Amiodarone, Cimetidine, Ciproflaxacin, Disul firam, Erythromycin, Interferon alfa, Isoniazid, Metamizole,


Metoprolol, Narfloxacin, Pefloxacin, Pentoxifylline, Prapafenane, Prapylthiouraeil,


Radioactive iodine, Tacrine, Thiabendazale,


Ticlopidine, Verapamil: Increased theophylline concentrations


Aminoglutethamide, Barbiturates, Carbamazepine,


Maricizine, Phenytoin, Rifampin, Ritanavir; Thyroid hormone: Reduced theophylline concentrations; decreased serum phenytoin levels


Beta-blackers: Reduced bronchodilating response to theophylline Enoxacin; Fluvoxamine, Mexiletine, Propranolal,


Troleandomycin: Markedly increased theophylline concentrations


Imipenem: Some patients on theophylline have developed seizures following addition of imipenem


Lithium: Reduced lithium concentrations


Smoking: Increased aminophylline dosing requirements


 


 

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

CNS: Anxiety, dizziness, headache, insomnia, lightheadedness, muscle twitching, reflex hyperexcitability, restlessness, seizures


CV: Circulatory failure, flushing, hy potension, palpitations, sinus tachy cardia, ventricular dysrhythmias


GI: Anal irritation (suppositories), anorexia, bitter taste, black stools, diarrhea, dyspepsia, epigastric pain, esophageal reflux, hematemesis, nausea, vomiting


GU: Proteinuria, urinary frequency


METAB: Hyperglycemia, S1ADH


RESP: Tachypnea


SKIN: Urticaria, alopecia

Patient And Carer Advice: